17-30971197-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000328381.10(RNF135):c.124C>T(p.Arg42Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000161 in 1,524,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000328381.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF135 | NM_032322.4 | c.124C>T | p.Arg42Cys | missense_variant | 1/5 | ENST00000328381.10 | NP_115698.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF135 | ENST00000328381.10 | c.124C>T | p.Arg42Cys | missense_variant | 1/5 | 1 | NM_032322.4 | ENSP00000328340 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000305 AC: 36AN: 117888Hom.: 0 AF XY: 0.000307 AC XY: 20AN XY: 65152
GnomAD4 exome AF: 0.000161 AC: 221AN: 1372178Hom.: 0 Cov.: 31 AF XY: 0.000158 AC XY: 107AN XY: 676828
GnomAD4 genome AF: 0.000158 AC: 24AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2022 | The c.124C>T (p.R42C) alteration is located in exon 1 (coding exon 1) of the RNF135 gene. This alteration results from a C to T substitution at nucleotide position 124, causing the arginine (R) at amino acid position 42 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | RNF135: BS1, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at